Influence of phenolic constituents from Yucca schidigera bark on arachidonate metabolism in vitro

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 19, 2008, Pages 8885-8890

  Wenzig, Eva M ^a   Oleszek, Wieslaw ^b   Stochmal, Anna ^b   Kunert, Olaf ^a   Bauer, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b STATE RESEARCH INSTITUTE   (Poland)

Author keywords

Cyclooxygenase; Lipoxygenase; Resveratrol; Yucca schidigera; Yuccaols

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; LEUKOTRIENE B4; PHENOL DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BARK; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; YUCCA;

ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; LEUKOTRIENE B4; PHENOLS; PLANT BARK; YUCCA;

AGAVACEAE; YUCCA SCHIDIGERA;

EID: 54349105755     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf801289m     Document Type: Article

References (29)

1. Cheeke, P. R.; Piacente, S.; Oleszek, W. Anti-inflammatory and anti-arthritic effects of Yucca schidigera: a review. J. Inflammation 2006, 3, 1-7.
2. Cheeke, P. R. Acutal and potential applications of Yucca schidigera and Quillaja saponaria saponins in human and animal nutrition. Proc. Am. Soc. Anim. Sci. 1999, 1-10.
3. King, R. E.; Bonser, J. A.; Min, D. B. Bioactivity of resveratrol. Compr. Rev. Food Sci. Food Saf. 2006, 5, 65-70.
4. Alarcón de la Lastra, C.; Villegas, I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical applications. Mol. Nutr. Food Res. 2005, 49, 405-430.
5. Olas, B.; Wachowicz, B.; Stochmal, A.; Oleszek, W. Inhibition of oxidative stress in blood platelets by different phenolics from Yucca schidigera Roezl. Bark. Nutrition 2003, 19, 633-640.
6. Olas, B.; Wachowicz, B.; Majsterek, I.; Blasiak, J.; Stochmal, A.; Oleszek, W. Antioxidant properties of trans-3,3′,5,5′- tetrahydroxy-4′-methoxystilbene against modification of variety of biomolecules in human blood cells treated with platinum compounds. Nutrition 2006, 22, 1202-1209.
7. Olas, B.; Wachowicz, B.; Stochmal, A.; Oleszek, W. Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. Bark. Platelets 2002, 13, 167-173.
8. Olas, B.; Wachowicz, B.; Stochmal, A.; Oleszek, W. Inhibition of blood platelet adhesion and secretion by different phenolics from Yucca schidigera. Roezl. Bark. Nutrition 2005, 21, 199-206.
9. Marzocco, S.; Piacente, S.; Pizza, C.; Oleszek, W.; Stochmal, A.; Pinto, A.; Sorrentino, R.; Autore, G. Inhibition of inducible nitric oxide synthase expression by yuccaol C from Yucca schidigera Roezl. Life Sci. 2004, 75, 1491-1501.
10. Calanni, F.; Laufer, S. Biochemistry and mediators of inflammation In Inflammation and Rheumatic Diseases. The Molecular Basis of Novel Therapies; Laufer, S.; Gay, S.; Brune, K., Eds.; Georg Thieme Verlag: Stuttgart, Germany, 2003; pp 15-57.
11. Mukherjee, D.; Nissen, S. E.; Topol, E. J. Risk of cardiovascular events associated with selective COX-2 inhibitors. J. Am. Med. Assoc. 2001, 286, 954-959.
12. Mattia, C.; Coluzzi, F. COX-2 inhibitors: pharmacological data and adverse effects. Minerva Anestesiol. 2005, 71, 461-470.
13. McAdam, B. F.; Catella-Lawson, F.; Mardini, I. A.; Kapoor, S.; Lawson, J. A.; Fitzgerald, G. A Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 272-277.
14. Oleszek, W.; Sitek, M.; Stochmal, A.; Piacente, S.; Pizza, C.; Cheeke, P. Resveratrol and other phenolics from the bark of Yucca schidigera Roezl. J. Agric. Food Chem. 2001, 49, 747-752.
15. Piacente, S.; Montoro, P.; Oleszek, W.; Pizza, C. Yucca schidigera bark: phenolic constituents and antioxidant activity. J. Nat. Prod. 2004, 67, 882-885.
16. Fiebich, B. L.; Grozdeva, M.; Hess, S.; Hüll, M.; Danasch, U.; Bodensieck, A.; Bauer, R. Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells. Planta Med. 2005, 71, 12-19.
17. Reininger, E. A.; Bauer, R. Prostaglandin-H-synthase (PGHS)-1 and -2 microtiter assays for the testing of herbal drugs and in vitro inhibition of PGHS-isoenzyms by polyunsaturated fatty acids from Platycodi radix. Phytomedicine 2006, 13, 164-169.
18. Adams, M.; Kunert, O.; Haslinger, E.; Bauer, R. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa. Planta Med. 2004, 70, 904-908.
19. Knödler, M.; Conrad, J.; Wenzig, E. M.; Bauer, R.; Lacorn, M.; Beifuss, U.; Carle, R.; Schieber, A. Anti-inflammatory 5-(11Z-heptadecenyl)- and 5-(8Z,11Z-heptadecadienyl)-resorcinol from mango (Mangifera indica L.) peels. Phytochemistry 2008, 69, 988-993.
20. Montoro, P.; Piacente, S.; Oleszek, W.; Pizza, C. Liquid chromatography/tandem mass spectrometry of unusual phenols from Yucca schidigera bark: comparison with other analytical techniques. J. Mass Spectrom. 2004, 39, 1131-1138.
21. Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J. M.; Dannenberg, A. I. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273, 21875-21882.
22. Martin, A. R.; Villegas, I.; La Casa, C.; de la Lastra, C. A. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol. 2004, 67, 1399-1410.
23. Szewczuk, L. M.; Forti, L.; Stivala, L. A.; Penning, T. M. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2. J. Biol. Chem. 2004, 279, 22727-22737.
24. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
25. Johnson, J. L.; Maddipati, K. R. Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins Other Lipid Mediat. 1998, 56, 131-143.
26. Rotondo, S.; Rajtar, G.; Manarini, S.; Celardo, A.; Rotilio, D.; de Gaetano, G.; Evangelista, V.; Cerletti, C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol. 1998, 123, 1691-1699.
27. Murias, M.; Handler, N.; Erker, T.; Pleban, K.; Ecker, G.; Saiko, P.; Szekeres, T.; Jäger, W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 2004, 12, 5571-5578.
28. Walle, T.; Faye, H.; DeLegge, M. H.; Oatis, J. E.; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
29. Meng, X.; Maliakal, P.; Lu, H.; Lee, M.-J.; Yang, C. S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 2004, 52, 935-942.